Oral available agents in the treatment of relapsing remitting multiple sclerosis an overview of merits and culprits (Q36648175)
scientific article published on February 26, 2013
Language:
(P31) (Q13442814)
(P275) (Q18810331)
(P304) 37-47
(P407) (Q1860)
(P478) 5
(P577) Tuesday, February 26, 2013
(P921) (Q8277)
(Q414030)
(Q3077133)
(Q3487584)
(P953) https://www.dovepress.com/getfile.php?fileID=15306
https://europepmc.org/articles/PMC3585507
https://europepmc.org/articles/PMC3585507?pdf=render
(P1433) (Q5308799)
(P1476) "Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits" (language: en)
"Oral available agents in the treatment of relapsing remitting multiple sclerosis an overview of merits and culprits" (language: en)
(P2093) Jan Thöne
Gisa Ellrichmann
(P2860) (Q28275399)
(Q34300614)
(Q36174480)
(Q38018673)
(Q34261244)
(Q37905767)
(Q28512659)
(Q37849014)
(Q34627230)
(Q37838439)
(Q28303514)
(Q37808485)
(Q37794267)
(Q34093899)
(Q28271008)
(Q28270998)
(Q35013390)
(Q28299151)
(Q34788240)
(Q34565985)
(Q40351427)
(Q36307847)
(Q34405210)
(Q37725229)
(Q43211470)
(Q48454882)
(Q48455059)
(Q47916199)
(Q48793112)
(Q48847857)
(Q45929870)
(Q53425063)
(Q44754660)
(Q42909983)
(Q48488976)
(Q48602930)
(Q44496335)
(Q84204557)
(P6216) (Q50423863)
other details
description scientific article published on February 26, 2013

External Links